Joseph Aslan
@JoePlatelet
Platelets - Cell biology - Signal transduction - Hematology - Cardiovascular Health & Disease
ID:1201227764109475840
https://www.ohsu.edu/people/joseph-e-aslan-phd-faha 01-12-2019 19:53:23
1,9K Tweets
1,7K Followers
3,4K Following
Follow People
Our OHSU Knight Cardio T32 has postdoc research fellowships available (for MDs and PhDs, etc.) - come work with us on #platelet #proteomics in #atherosclerosis or #TAVR or #amyloidosis or #vasculardevicethrombosis - apply by April 30
Excited to co-chair the women’s health track w/ Dr. Pilar de la Puente for this year’s Biomedical Engineering Society meeting!
Heart, lung and blood scientists looking for inspiration and a career boost .. first NIH NHLBI R01? Check out the UC San Diego UCSD Health Sciences Office of Faculty Affairs Summer institute FOCUS program (apps due March 31st) AHA Science ASH American Lung Association American Heart Association American College of Cardiology
Heartbroken to hear of the passing of one of my biggest supporters, drchuckchan.
Chuck was a beacon of creativity, excitement, and inspiration -- SIM1's 'favorite camp counselor' as Michal Tal, PhD once put it.
Already missing you lots. Many hugs to your loved ones.
My department at KTH Royal Institute of Technology SciLifeLab is recruiting an Assistant Professor in computational biology! Fantastic academic environment, top notch infra, colleagues and students, international vibe, Sweden is a lovely place to live. More info 👇
kth.se/lediga-jobb/68…
After serving as OHSU Knight Cancer Institute's director for 17+ years, Dr. Brian Druker will take on a new role as the institute’s chief executive officer.
Dr. Tom Sellers steps in as the new director after being recruited in February 2023 as chief research officer: spr.ly/6015kTvC5
Phase Ib/2a randomised, placebo controlled trial of glenzocimab published today in The Lancet Neurology
Glenzocimab is a platelet GpVI inhibitor. ACTIMIS trial used it as add on therapy in acute treatment of stroke.
thelancet.com/journals/laneu…
When #DOACs are ✅,📛, or ❓for Tx JACC Journals. Proud of 🌠post-docs Antoine Bejjani, MD & C. Dini Khairani, MD, MMSc.
We discuss where there is evidence of efficacy/safety, where there may be harm (safety or efficacy), and uncertainties Brigham and Women’s Research ... 🧵
👇
jacc.org/doi/10.1016/j.…
Apply! APPLY! Apply!👇
The deadline for #VascularDiscovery24 has been extended and competing for the #BrinkhousAward in #Thrombosis is an honor.
Instructions are found here (DM with questions):
professional.heart.org/en/partners/aw…